Congress:
ECR25
Poster Number:
C-23126
Type:
Poster: EPOS Radiologist (scientific)
DOI:
10.26044/ecr2025/C-23126
Authorblock:
E. Pershina, K. Kovalev, Z. Magomedova, D. Shchekochikhin; Moscow/RU
Disclosures:
Ekaterina Pershina:
Nothing to disclose
Konstantin Kovalev:
Nothing to disclose
Zaynab Magomedova:
Nothing to disclose
Dmitry Shchekochikhin:
Nothing to disclose
Keywords:
Cardiac, MR, Contrast agent-intravenous, Hyperplasia / Hypertrophy, Tissue characterisation
There are numerous causes of left ventricular hypertrophy (LVH), ranging from physiological adaptation to athletic training or increased afterload to more severe pathological hypertrophy, as seen in hypertrophic cardiomyopathy. Differentiating pathological hypertrophy from physiological hypertrophy can be challenging, but it is crucial for determining the prognosis and treatment. Cardiac magnetic resonance (CMR) strain imaging, using both 2D and 3D modalities, is an emerging non-invasive tool for myocardial tissue characterization. This study aims to evaluate the effectiveness of CMR-derived strain parameters in distinguishing between hypertrophic cardiomyopathy (HCM) and left ventricular hypertrophy (LVH)